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Abstract: There are more than 100 different ribonucleoside structures incorporated as  
post-transcriptional modifications, mainly in tRNA and rRNA of both prokaryotes and 
eukaryotes, and emerging evidence suggests that these modifications function as a system 
in the translational control of cellular responses. However, our understanding of this 
system is hampered by the paucity of information about the complete set of RNA 
modifications present in individual organisms. To this end, we have employed a 
chromatography-coupled mass spectrometric approach to define the spectrum of modified 
ribonucleosides in microbial species, starting with Mycobacterium bovis BCG. This 
approach revealed a variety of ribonucleoside candidates in tRNA from BCG, of which 12 
were definitively identified based on comparisons to synthetic standards and 5 were 
tentatively identified by exact mass comparisons to RNA modification databases. Among 
the ribonucleosides observed in BCG tRNA was one not previously described in tRNA, 
which we have now characterized as N6,N6-dimethyladenosine. 
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1. Introduction 
While the four canonical nucleobases in DNA are adequate to encode the genome, the functional 
diversity of RNA is greatly enhanced by the presence of over 100 different targeted structural 
modifications of the nucleobase and ribose sugar in RNA across all organisms [1,2]. Transfer RNA 
(tRNA) and ribosomal RNA (rRNA) are the most frequently modified forms of RNA, though other 
species such as messenger RNA (mRNA) and microRNAs are also known to possess specific 
ribonucleoside modifications, such as the N7-methylguanosine cap on mRNA. 
Emerging evidence points to important roles for RNA modifications in translational control of 
cellular responses to stress and other stimuli [3-6]. For example, we recently observed that exposure of 
the yeast Saccharomyces cerevisiae to cytotoxic chemicals causes a reprogramming of the spectrum of 
two dozen RNA modifications in tRNA, with a unique ribonucleoside signature for each agent [7]. 
These observations point to the importance of fully understanding the structure and function of 
ribonucleoside analogs in both eukaryotic and prokaryotic organisms. 
To this end, we have undertaken a systematic characterization of RNA modifications in a variety of 
pathological microorganisms, including mycobacteria. Infection with Mycobacterium tuberculosis 
(Mtb) represents one of the most widespread diseases in the world, with nearly one-third of the World's 
population showing signs of exposure, more than 20 million people actively infected, and almost  
80% of the population of some developing countries testing positive in tuberculin tests [8,9]. 
Mycobacterium bovis Bacille Calmette-Guérin (BCG) is a mycobacterial species closely related to Mtb 
and is widely used as a vaccine [10]. To understand the biological roles of tRNA modifications in 
mycobacteria, we have begun to characterize the RNA modifications in BCG, with the discovery of 
N6,N6-dimethyladenosine in mycobacterial tRNA. 
2. Results and Discussion 
2.1. Isolation of tRNA 
As the spectrum of modified nucleosides may vary significantly under different cell culture 
conditions and different stages of cell growth, we adopted a standard approach to BCG culture 
conditions by harvesting cells in log-phase growth at an OD600 of ~0.6, which occurred on day ~7 
under our culture conditions. The procedure used to isolate small RNA species yielded ~4 μg of high 
quality tRNA from 109 BCG cells. As shown in Figure 1, tRNA represented >95% of the RNA present 
in the sample. The average size of the major RNA peak was determined to be ~65 nt, which is 
consistent with the predicted size of tRNA in BCG [11]. One important issue relevant to these studies 
was the possibility of contamination of tRNA with 5S rRNA. In BCG, 5S rRNA is 115 nt in length [12] 
and there were no detectable RNA species of this size in the small RNA isolates prepared for the 
present studies (Figure 1). 
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Figure 1. Characterization of BCG small RNA species. An aliquot of small RNA isolated 
from BCG was analyzed on an Agilent Bioanalyzer small RNA chip. The peak at 4 nt in 
the electropherogram represents a size standard; the image on the right is the reconstructed 
gel image of the resolved RNA species. 
 
2.2. Identification of Ribonucleosides in BCG tRNA 
As a critical feature of our platform for studying the complete set of ribonucleosides in an organism [7], 
liquid chromatography-coupled mass spectrometry has previously been demonstrated to be a powerful tool 
for characterizing the structure of ribonucleosides and for quantifying them in biological systems [13,14]. 
Ribonucleosides from hydrolyzed tRNA were initially characterized using LC-MS/MS with neutral 
loss analysis. During CID, there is characteristic cleavage of the glycosidic bond between the 
nucleobase and either the ribose or 2’-O-methylribose moiety, which causes a loss of either 132 or 146 
amu, respectively. We used this property to search for modified nucleosides, with parallel analysis of a 
sample prepared without added RNA to account for artifacts. It should be noted that, since the C–C 
glycosidic bond in pseudouridine (Y) does not readily fragment to produce neutral loss of a ribose 
residue, the presence of Y was verified by CID fragmentation of the ribose to yield the nucleobase 
with the ribose C1 methylene group attached (m/z 125; [15]). 
This analysis revealed several ribonucleoside candidates (Figure 2). Of these, 12 were definitively 
identified by comparison of retention time, exact mass and CID fragmentation to synthetic standards, 
while another five were tentatively identified on the basis of exact mass comparisons to RNA 
modification databases [1,2], with no specific structures that can be assigned to the isobaric methylated 
ribonucleosides (Table 1). 
2.3. Structural Characterization of the Ribonucleoside with m/z 296.1350 
One of the ribonucleosides identified in neutral loss analysis had a m/z value of 296.1350 ± 0.0011 
(mean ± SD; Figures S1 and S2), which yields a chemical formula of C12H18N5O4+ (m/z 296.1359). 
This formula corresponded to an adenosine with 2 methyl groups or 1 ethyl group. Subsequent MS2 
analysis confirmed the neutral loss of ribose to yield a fragment with m/z 164.0924 (Figure 3), which 
corresponds to an adenine nucleobase with an additional C2H4 (m/z 164.0936). Pseudo-MS3 analysis 
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consisted of in-source fragmentation-induced loss of ribose to yield an ion with m/z 164.09, which was 
selected for CID in the second quadrupole. The resulting mass spectrum shown in Figure 4 revealed a 
variety of fragment ions, many of which had m/z values associated with fragmentation of methylated 
adenosine [16]. Based upon this dissociation model and the fragmentation pattern, we concluded that 
the structure of the ion with m/z 296.1350 was N6,N6-dimethyladenosine (m62A). This was confirmed 
by comparison to synthetic m62A, which produced identical values for retention time, exact mass, and 
MS2 and pseudo-MS3 fragmentation (Figure 5). 
Figure 2. Extracted ion chromatogram of ribonucleoside candidates in hydrolyzed BCG 
tRNA identified by LC-MS/MS in neutral loss mode. The peaks of m1A (2.5 min) and m7G 
(3.9 min) are marked with ‘//’ to indicate that they are in different scales from other peaks. 
The identities of ribonucleosides marked with ‘?’ are tentative and have not been 
confirmed against standards. ‘mA’ denotes a monomethylated adenosine. 
 
Table 1. Ribonucleosides identified by mass spectrometric analysis of BCG tRNA hydrolysates 1. 
Retention time, 
min 1 
Precursor ion, 
m/z 
Product ion, 
m/z Signal Intensity Identity 
2 
1.43 245.1 125.1 110 Y 
2.15 258.1 126.1 70 m5C 
2.45 258.1 126.1 279 m3C 
2.47 282.1 150.1 500000 m1A 
3.85 298.1 166.1 500000 m7G 
4.22 258.1 112.1 2500 Cm 
4.4 269.1 137.1 80000 I 
5.16 352 220 16000 io6A? 
5.27 322 190 24000 imG-14? 
8.22 259.1 127.1 30 m5U 
8.6 282.1 150.1 7000 mA, Am? 
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Table 1. Cont. 
10.69 298.1 166.1 3500 m1G? 
11.4 298.1 152.1 450 Gm 
12.9 282.1 150.1 17000 mA, Am? 
13.91 298.1 166.1 600 m2G 
20.1 296.1 164.1 25000 m62A 
21.88 413.1 281.1 2500 t6A 
1 Neutral loss analysis (except for Y) was performed with a triple quadrupole mass spectrometer, as 
described in the Experimental section; 2 RNA modifications noted in bold font were corroborated 
with synthetic standards. “?” denotes tentative identification; “mA, Am” denotes a monomethylated 
adenosine. 
Figure 3. MS2 fragmentation of the ribonucleoside with m/z 296.1350. 
 
2.4. Quantification of m62A in tRNA from Different Organisms 
Since m62A had been described in rRNA previously but not in tRNA, we quantified this 
modification by LC-MS/MS in samples of tRNA from M. bovis BCG, rat liver tissue, TK6 cell line, 
and yeast by using external calibration against dA (Figures S3 and S4). In M. bovis BCG, the level of 
m62A was 0.88 pmol per μg of tRNA, while the level of m62A in rat liver, and TK6 and yeast cells was 
below the detection limit of the assay. On average, the size of mycobacterial tRNA is ~65 nt, which 
suggests that m62A occurs once in every ~51 tRNA molecules. The data in Table 2 also suggest that 
the presence of m62A in the small RNA isolates is not due to contamination with rRNA fragments, 
since we would have expected to detect m62A in the small RNA isolates from the other species if 
rRNA fragment contamination had occurred. To further confirm this, tRNA was purified from samples 
of BCG small RNA by size-exclusion HPLC (Figure S5) and m62A was again detected in the fraction 
containing only tRNA (data not shown). 
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Figure 4. Pseudo-MS3 fragmentation of m/z 164.0924 derived from the m/z 296.1350 
ribonucleoside. Tentative structures of fragment ions are based on a model proposed by 
Nelson and McCloskey [18]. 
 
Figure 5. Pseudo-MS3 fragmentation of m/z 164.0924 derived from the m/z 296.1350 ion 
of synthetic m62A. 
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Table 2. Level of m62A in tRNA from BCG, human, rat and yeast. 
 BCG Human TK6 Rat liver S. cerevisiae  
MS signal1 5.8 ± 0.9 <0.0062 <0.0062 <0.0062 
pmol/μg tRNA 0.88 ± 0.14 < 0.00092 < 0.00092 < 0.00092 
1 MS signal normalized to total tRNA (0.4 μg); 2 Less than the limit of quantification. 
2.5. Discussion 
Using an LC-MS platform developed for analysis of ribonucleoside modifications in yeast [7], we 
have begun to systematically characterize the spectrum of modified ribonucleosides in a variety of 
microorganisms, starting with Mycobacterium bovis BCG. The platform that we have developed 
addresses all levels of highly quantitative analysis, including isolation of high quality RNA (Figure 1), 
rigorous quantification of the RNA, and RNA processing under conditions that obviate modification 
artifacts caused by adventitious oxidation (addition of deferoxamine and butylated hydroxytoluene) 
and deamination (addition of coformycin and tetrahydrouridine). Subsequent resolution of the 
complete set of ribonucleosides by reversed-phase HPLC provides good separation (Figure 2) for mass 
spectrometric characterization for both high mass accuracy and fragmentation. Using this approach, we 
were able definitively identify 12 modified ribonucleosides in BCG tRNA: Y, m5C, m3C, m1A, m7G, 
Cm, I, m5U, Gm, m2G, t6A, and m62A. All of these species have been described previously in  
either tRNA or rRNA from other organisms [17,18], which suggests conservation of function in 
mycobacteria. Of these ribonucleosides, only 1-methyladenosine (m1A) has been previously identified 
in a mycobacterial species (Mtb), where it occurs at position 58 of tRNA [18,19]. While m1A and m7G 
are highly abundant in both BCG and yeast tRNA, the relative proportions of other ribonucleosides 
common to both organisms differ significantly, as judged from mass spectrometric signal strength 
under identical analytical conditions (Figure 2 in the present studies and Figure 1 in [7]). 
In addition to the 12 defined ribonucleosides, we tentatively identified five other ribonucleosides on 
the basis of CID molecular transitions and exact mass comparisons with RNA modification databases: 
N6-(cis-hydroxyisopentenyl)adenosine (io6A; m/z 352.1616; m/z 352→220), 4-demethylwyosine (imG-14; 
m/z 322.1146; m/z 322→190), two adenosine species in which the nucleobase is methylated  
(m/z 282.1197; m/z 282→150) and a species in which the guanosine nucleobase is methylated  
(m/z 298.1146; m/z 298→166). The latter is likely to be m1G since no other mono-methylated 
guanosines than Gm, m2G and m7G have been described [19,20]. Possible candidates for mono-methylated 
adenosine include Am, m2A m8A, m6A; m7A has not been described previously [17,18]. These 
modifications have been observed in tRNA in other organisms [17,18]. 
Our initial analysis of ribonucleosides in BCG tRNA revealed an abundant (Figure 2) 
ribonucleoside not previously identified in tRNA: an adenosine species with either an ethyl group or 
two methyl groups attached to the nucleobase. Among the possible candidates for this species were 
1,2-O-dimethyladenosine (m1Am), N6,2-O-dimethyladenosine (m6Am) and N6,N6-dimethyladenosine 
(m62A) [17,18]. As shown in Figures 3 and 4, MS2 and pseudo-MS3 fragmentation suggested that the 
structure was m62A, a conclusion corroborated by comparison to a synthetic m62A standard (Figure 5). 
The nucleoside m62A was discovered by Littlefield and Dunn in Bacterium coli, Aerobacter aerogenes, 
yeast, and rat liver tissues [20]. It was identified in the 16S and 23S rRNA of archaea and bacteria and 
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the 18S rRNA of eukarya [21-25]. However, m62A has not been identified in tRNA from any organism 
or cell types other than BCG, including yeast, rat liver and human cells (Table 2). That the m62A did 
not arise from contamination of small RNA isolates with 5S rRNA or fragments of larger rRNA 
species is supported by the results in Table 2, the Bioanalyzer results in Figures 1 and S4, and the 
analysis of HPLC-purified tRNA from BCG. 
While m62A has been observed previously only in rRNA, several features of its structure and 
biosynthesis may provide insights into its presence in tRNA. An examination of ribonucleoside 
databases reveals that adenosine species with N6 modifications (e.g., t6A, i6A) tend to be located at 
position 37 of tRNA, which suggests a possible location for the similarly hydrophobic m62A in tRNA 
in BCG and other mycobacterial species. Orthologs of the methyltransferase KsgA catalyze the 
formation of m62A in the 3’-ends of the small subunit rRNAs in most organisms [26], while members of 
the Erm family of methyltransferases catalyze m62A formation in 23S rRNA in many bacteria [27,28]. 
Homologs of both Erm and KsgA are present in BCG and Mtb [12,29]. Given the precedent for m5U 
formation in both tRNA and 16S rRNA by the tRNA (m5U54) methyltransferase [30,31], it is possible 
that the KsgA or Erm homologs also catalyze m62A formation in BCG tRNA. 
3. Experimental 
3.1. Materials and Equipment 
All chemicals and reagents were of the highest purity available and were used without further 
purification. OADC solution, 7H9 culture media powder, and 7H11 agar powder were purchased from 
Biomed Diagnostics (White City, OR, USA). Trizol reagent and PureLink miRNA Isolation Kit was 
purchased from Invitrogen (Carlsbad, CA, USA). 2’-O-Methyluridine (Um), pseudouridine (Y),  
N1-methyladenosine (m1A), N2,N2-dimethylguanosine (m22G), N6,N6-dimethyladensoine (m62A), and 
2’-O-methylguanosine (Gm) were purchased from Berry and Associates (Dexter, MI, USA).  
N6-threonyl-carbamoyladenosine (t6A) was purchased from Biolog (Bremen, Germany).  
N6-isopentenyladenosine (i6A) was purchased from International Laboratory LLC (San Bruno, CA, 
USA). 2’-O-Methyladenosine (Am), N4-acetylcytidine (ac4C), 5-methyluridine (m5U), inosine (I),  
2-methylguanosine (m2G), N7-methylguanosine (m7G), 2’-O-methylcytidine (Cm), 3-methylcytidine 
(m3C), 5-methylcytidine (m5C), alkaline phosphatase, RNase A, ammonium acetate, geneticine, bovine 
serum albumin, deferoxamine mesylate, butylated hydroxytoluene, glucose, sodium chloride, nuclease 
P1, formic acid, and 20% Tween80 solution were purchased from Sigma Chemical Co. (St. Louis, 
MO, USA). Glycerol was purchased from SinoChem Corp. (Beijing, China). Phosphodiesterase I was 
purchased from USB (Cleveland, OH, USA). RNase A, RNase V1 and RNase T1 were purchased from 
Ambion Inc. (Austin, TX, USA). HPLC-grade water, acetonitrile, and chloroform were purchased 
from Mallinckrodt Baker (Phillipsburg, NJ, USA). M. bovis BCG and S. cerevisiae were purchased 
from American Type Culture Collections (Manassas, VA, USA). Rat liver tissue (discarded) was 
obtained from Laura J. Trudel (Department of Biological Engineering, Massachusetts Institute of 
Technology). Filters with a 10 KDa MW cut-off were purchased from Pall Life Sciences (Port 
Washington, NY, USA). Experiments were performed with Thermo FP120 Bead beater (Two Rivers, 
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WI, USA), Qiagen TissueRuptor (Valencia, CA, USA), Agilent Bioanalyzer series 2100, Agilent 
LC/QQQ 6460, Agilent LC/TOF G6210A, and Agilent LC/QTOF 6520 (Santa Clara, CA, USA). 
3.2 Culturing BCG 
Mycobacterium bovis BCG cells were grown in 7H9 culture media (see Supporting Information) at 
37 °C in an incubator with 5% CO2. After the culture reached an optical density of OD600 ~0.6, at 
which point the concentration of cells was ~3 × 107/mL, the cells were harvested by centrifugation at 
12,000 × g for 10 min at 4 °C. Cell pellets were snap-frozen in liquid nitrogen and stored at −80 °C. 
For glycerol stocks, the post-centrifugation cell pellet was resuspended in 1 mL of 7H9 media with 
25% glycerol. The solution was then further diluted to a final concentration with OD600~1 and the 
stocks stored at −80 °C. To determine the quantity of living cells in a glycerol stock or a culture, 
colony counting was performed for each cell sample with 100 μL of serial dilutions plated on 7H11 
agar and incubated at 37 °C with 5% CO2 (see Supporting Information). 
3.3. Isolation of tRNA 
tRNA was isolated from several organisms, including BCG (~109 cells), S. cerevisiae (5 × 107 cells), 
human B lymphoblastoid TK6 cells (3 × 107 cells), and rat liver (~150 mg). Cells or tissues were 
suspended in 1.5 mL of Trizol reagent with 5 mg/mL coformycin, 50 μg/mL tetrahydrouridine, 0.1 mM 
deferoxamine mesylate, and 0.5 mM butylated hydroxytoluene to prevent nucleoside modification 
artifacts [32,33]. BCG and S. cerevisiae cells were lysed by 3 cycles of bead beating in a Thermo 
FP120 Bead Beater set at 6.5 m/s for each 20 s cycle, with 1 min of cooling on ice between cycles. The 
TK6 cells and rat liver tissue were lysed with a Qiagen TissueRuptor. Following cell or tissue 
disruption, all lysates were warmed to ambient temperature for 5 min and extracted with 0.3 mL 
volume of chloroform, with subsequent incubation at ambient temperature for 3 min. The solutions 
were centrifuged at 12,000 × g for 15 min at 4 °C and the aqueous phase was collected. Absolute 
ethanol was added to the aqueous phase (35% v/v) and small RNA species were then isolated using the 
PureLink miRNA Isolation Kit according to manufacturer’s instructions. The quality and concentration 
of the resulting small RNA mixture was assessed with a Bioanalyzer (Agilent Small RNA Kit), with 
tRNA comprising >95% of the small RNA species present in the mixture, with no detectable 5S rRNA 
(Figure 1). In one study, tRNA was purified from BCG small RNA isolates by size-exclusion HPLC 
using an Agilent SEC3 300 Å, 7.8 × 300 mm column eluted with 10 mM ammonium acetate. The 
tRNA fraction was collected and desalted using an Ambion Millipore 5K MWCO column. 
3.4. Enzymatic Hydrolysis of BCG tRNA 
Samples of purified RNA (6 μg) were lyophilized and redissolved in 100 μL of 10 ng/mL RNase A, 
0.01 U/mL RNase T1, 0.001 U/mL RNase V1, 0.15 U/mL nuclease P1, 2.5 mM deferoxamine 
mesylate, 10 ng/mL coformycin, 50 μg/mL tetrahydrouridine, 0.5 mM butylated hydroxytoluene, and 
1 × RNA Structure Buffer from Ambion. The solution was incubated at 37 °C for 3 h, after which 
alkaline phosphatase was added to a final concentration of 0.1 U/mL. The sample was incubated at 37 °C 
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overnight, followed by removal of proteins by YM10 filtration. The resulting filtrate was used directly 
for mass spectrometric analysis. 
3.5. Identification of Ribonucleosides in Small RNA from BCG 
Hydrolyzed RNA was resolved on a Thermo Hypersil Gold aQ column (100 × 2.1 mm, 1.9 μm 
particle size) with an acetonitrile gradient (HPLC system A) in 0.1% (v/v) formic acid in water as 
mobile phase at a flow rate of 0.3 mL/min. The gradient of acetonitrile in 0.1% formic acid was as 
follows: 0–15.3 min, 0%; 15.3–18.7 min, 1%; 18.7–20 min, 6%; 20–24 min, 6%; 24–27.3 min, 100%; 
27.3–41 min, 0%. The HPLC column was directly connected to a triple quadrupole mass spectrometer 
(Agilent LC/QQQ 6460) in positive ion, neutral loss mode for loss of m/z 132 and 146 in the range of m/z 
200–700. The voltages and source gas parameters were as follows: Gas temperature, 300 °C; gas flow, 
6 L/min; nebulizer, 15 psi; and capillary voltage, 4000 V. The ions detected in neutral loss mode  
were selected for identification with the LC-MS/MS system in multiple reaction monitoring (MRM) 
mode using the same HPLC and mass spectrometer parameters. Since the C–C glycosidic bond in 
pseudouridine (Y) does not readily fragment to produce neutral loss of a ribose residue, the presence of 
Y was verified by CID fragmentation of the ribose to yield the nucleobase with the ribose C1 
methylene group attached (m/z 125; [15]). 
3.6. High Mass-Accuracy Mass Spectrometric Analysis of Candidate Ribonucleosides 
The exact molecular weights of candidate ribonucleosides were determined by HPLC-coupled high 
mass-accuracy quadrupole time-of-flight mass spectrometry (Agilent LC/QTOF 6520). Hydrolyzed 
RNA samples were resolved on a Thermo Hypersil Gold aQ column (150 × 2.1 mm, 3 μm particle 
size) eluted with a mobile phase as noted earlier with the following solvent schedule for acetonitrile in 
0.1% formic acid: 0–23 min, 0%; 23–28 min, 2%; 28–36 min, 7%; 36–47 min, 100%; 47–67 min, 0% 
(HPLC system, B). The HPLC system was coupled to an Agilent QTOF 6520 Mass Spectrometer 
operated in positive ion mode scanning m/z 100–1700 with the following parameters: gas temperature, 
325 °C; drying gas, 5 L/min; nebulizer, 30 psi; and capillary voltage, 3500 V. 
3.7. Structural Characterization of N6,N6-Dimethyladenosine in BCG Small RNA 
The ribonucleoside-like species eluting at 20.1 min and possessing an [M+H]+ ion with m/z of 
296.1337 was subjected to structural characterization by collision-induced dissociation (CID) using 
both MS2 and pseudo-MS3 (i.e., in-source fragmentation) performed on the LC-QTOF system using a 
Thermo Hypersil Gold aQ column (100 × 1 mm, 3 μm particle size) at a flow rate of 90 μL/min using 
the same mobile phase described earlier, with a solvent schedule for the 0.1% formic acid in 
acetonitrile as follows: 0–18 min, 0%; 18–30 min, 7%; 30–44 min, 100%; and 44–60 min, 0% (HPLC 
system C). The mass spectrometer was operated in positive ion mode with the following voltages and 
source gas parameters: gas temperature, 325 °C; drying gas, 8 L/min; nebulizer, 30 psi; capillary 
voltage, 3500 V. The m/z detection range for parent ions was 100 to 800 and that for product ions was 
50 to 800. For MS2 analysis, the fragmentor voltage was 85 V, the collision energy was 10 V and the 
target ion for the unknown was m/z 296.1, while the fragmentor voltage was increased to 250 V for 
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MS3 analysis, which caused an in-source fragmentation of m/z 296.1 to give m/z 164.1 for further CID 
analysis. The m/z 164.1 ion was fragmented with collision energies of 0 V, 20 V, 30 V, and 60V. 
3.8. Quantification of N6,N6-Dimethyladenosine in tRNA from BCG and Other Organisms 
Absolute quantification of N6,N6-dimethyladenosine (m62A) was achieved by LC-MS/MS as 
described earlier, with [15N]5-2-deoxyadenosine ([15N]-dA) as the internal standard. For unknown 
tRNA samples, 4 pmol of [15N]-dA was added to 4 μg of tRNA and the samples were subjected to 
enzymatic hydrolysis as described earlier. Following volume adjustment to achieve final 
concentrations of ~40 nM [15N]-dA and ~40 ng/μL ribonucleosides, 10 μL of sample was analyzed by 
LC-MS/MS. Ribonucleosides were resolved on a Thermo Hypersil Gold aQ column (100 × 2.1 mm, 
1.9 μm particle size) with 0.1% (v/v) formic acid in water and in acetonitrile as mobile phase and a 
flow rate of 0.3 mL/min. The solvent schedule for acetonitrile in 0.1% formic acid was as follows:  
0–10 min, 5%; 10–12 min, 30%; 12 min, 95%. Electrospray ionization MS/MS analysis of the HPLC 
eluant was performed in positive ion mode with the following parameters for voltages and source gas: 
Gas temperature, 350 °C; gas flow, 10 L/min; nebulizer, 20 psi; and capillary voltage, 3500 V. The 
mass spectrometer was operated in MRM mode to quantify two ribonucleosides with the following 
parameters (retention time, m/z of the transmitted parent ion, m/z of the monitored product ion, 
fragmentor voltage, collision energy): [15N]-dA—3.0 min, m/z 257→141, 90 V, 10 V; and m62A— 
11.1 min, m/z 296→164, 90 V, 15 V. The dwell time for each ribonucleoside was 200 ms and these two 
ions were monitored throughout the HPLC run. Linear calibration curves were obtained using a fixed 
concentration (40 nM) of [15N]-dA and varying concentrations of m62A (5, 10, 50, 100, 500 nM). 
4. Conclusions 
We have employed a chromatography-coupled mass spectrometric approach to systematically 
define the spectrum of modified ribonucleosides in Mycobacterium bovis BCG. This approach 
revealed a variety of ribonucleoside candidates in tRNA from BCG, of which 12 were definitively 
identified based on comparisons to synthetic standards and 5 were tentatively identified by exact mass 
comparisons to RNA modification databases. Among the ribonucleosides observed in BCG tRNA was 
one not previously described in tRNA, which we have now characterized as N6,N6-dimethyladenosine. 
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Supplementary Materials can be accessed at http://www.mdpi.com/1420-3049/16/6/5168/s1. 
Acknowledgments 
The authors gratefully acknowledge a gift of rat liver tissue from Laura Trudel (Department of 
Biological Engineering, MIT). This work was supported by the Singapore-MIT Alliance for Research 
and Technology, a grant from the National Institute of Environmental Health Sciences (ES017010) and 
the MIT Westaway Fund. Mass spectrometric analyses were performed, in part, in the Bioanalytical 
Facilities Core of the MIT Center for Environmental Health Science, which is supported by NIEHS 
Center grant ES002109. CTYC was supported by a Merck-CSBi Fellowship. 
Molecules 2011, 16              
 
5179
Conflict of Interest 
The authors declare no conflict of interest. 
References 
1. Czerwoniec, A.; Dunin-Horkawicz, S.; Purta, E.; Kaminska, K.H.; Kasprzak, J.M.; Bujnicki, J.M.; 
Grosjean, H.; Rother, K. MODOMICS: A database of RNA modification pathways. Nucl. Acid. 
Res. 2009, 37, D118-D121. 
2. McCloskey, J.A.; Rozenski, J. The small subunit rRNA modification database. Nucl. Acid. Res. 
2005, 33, D135-D138. 
3. Bennett, C.B.; Lewis, L.K.; Karthikeyan, G.; Lobachev, K.S.; Jin, Y.H.; Sterling, J.F.; Snipe, J.R.; 
Resnick, M.A. Genes required for ionizing radiation resistance in yeast. Nat. Genet. 2001, 29, 
426-434. 
4. Kalhor, H.R.; Clarke, S. Novel methyltransferase for modified uridine residues at the wobble 
position of tRNA. Mol. Cell. Biol. 2003, 23, 9283-9292. 
5. Alexandrov, A.; Grayhack, E.J.; Phizicky, E.M. tRNA m7G methyltransferase Trm8p/Trm82p: 
Evidence linking activity to a growth phenotype and implicating Trm82p in maintaining levels of 
active Trm8p. RNA 2005, 11, 821-830. 
6. Begley, U.; Dyavaiah, M.; Patil, A.; Rooney, J.P.; Direnzo, D.; Young, C.M.; Conklin, D.S.; 
Zitomer, R.S.; Begley, T.J. Trm9-catalyzed tRNA modifications link translation to the DNA 
damage response. Mol. Cell 2007, 28, 860-870. 
7. Chan, C.T.; Dyavaiah, M.; DeMott, M.S.; Taghizadeh, K.; Dedon, P.C.; Begley, T.J.  
A quantitative systems approach reveals dynamic control of tRNA modifications during cellular 
stress. PLoS Genet. 2010, 6, e1001247. 
8. Jasmer, R.M.; Nahid, P.; Hopewell, P.C. Clinical practice. Latent tuberculosis infection. N. Engl. 
J. Med. 2002, 347, 1860-1866. 
9. World Health Organization, G.T.P. Global tuberculosis control: WHO report; Number 
WHO/HTM/TB/2009.411; Global Tuberculosis Programme, Geneva, Switzerland, 2009. 
10. Fine, P.E.; Rodrigues, L.C. Modern vaccines. Mycobacterial diseases. Lancet 1990, 335, 1016-1020. 
11. Chan, P.P.; Lowe, T.M. GtRNAdb: A database of transfer RNA genes detected in genomic 
sequence. Nucl. Acid. Res. 2009, 37, D93-D97. 
12. Brosch, R.; Gordon, S.V.; Garnier, T.; Eiglmeier, K.; Frigui, W.; Valenti, P.; Dos Santos, S.; 
Duthoy, S.; Lacroix, C.; Garcia-Pelayo, C.; et al. Genome plasticity of BCG and impact on 
vaccine efficacy. Proc. Natl. Acad. Sci. USA 2007, 104, 5596-5601. 
13. Suzuki, T.; Ikeuchi, Y.; Noma, A.; Sakaguchi, Y. Mass spectrometric identification and 
characterization of RNA-modifying enzymes. Methods Enzymol 2007, 425, 211-229. 
14. Meng, Z.; Limbach, P.A. Mass spectrometry of RNA: Linking the genome to the proteome. Brief 
Funct Genomic Proteomic 2006, 5, 87-95. 
15. Dudley, E.; Tuytten, R.; Bond, A.; Lemiere, F.; Brenton, A.G.; Esmans, E.L.; Newton, R.P. Study 
of the mass spectrometric fragmentation of pseudouridine: comparison of fragmentation data 
obtained by matrix-assisted laser desorption/ionisation post-source decay, electrospray ion trap 
Molecules 2011, 16              
 
5180
multistage mass spectrometry, and by a method utilising electrospray quadrupole time-of-flight 
tandem mass spectrometry and in-source fragmentation. Rapid Commun. Mass Spectrom 2005, 
19, 3075-3085. 
16. Nelson, C.C.M.; McCloskey, J.A. Collision-induced dissociation of adenine. J. Am. Chem. Soc. 
1992, 114, 3661 to 3668. 
17. Brahmachari, V.; Ramakrishnan, T. Studies on 1-methyl adenine transfer RNA methyltransferase 
of Mycobacterium smegmatis. Arch. Microbiol. 1984, 140, 91-95. 
18. Varshney, U.; Ramesh, V.; Madabushi, A.; Gaur, R.; Subramanya, H.S.; RajBhandary, U.L. 
Mycobacterium tuberculosis Rv2118c codes for a single-component homotetrameric m1A58 
tRNA methyltransferase. Nucl. Acid. Res. 2004, 32, 1018-1027. 
19. Bujnicki, J.M. In silico analysis of the tRNA:m1A58 methyltransferase family: homology-based 
fold prediction and identification of new members from Eubacteria and Archaea. FEBS Lett. 
2001, 507, 123-127. 
20. Littlefield, J.W.; Dunn, D.B. The occurrence and distribution of thymine and three methylated-
adenine bases in ribonucleic acids from several sources. Nature 1958, 181, 254-255. 
21. Brown, G.M.; Attardi, G. Methylation of nucleic acids in HeLa cells. Biochem. Biophys. Res. 
Commun. 1965, 20, 298-302. 
22. Dubin, D.T.; Günalp, A. Minor nucleotide composition of ribosomal precursor, and ribosomal, 
ribonucleic acid in Escherichia coli. Biochim. Biophys. Acta 1967, 134, 106-123. 
23. Fox, G.E.; Magrum, L.J.; Balch, W.E.; Wolfe, R.S.; Woese, C.R. Classification of methanogenic 
bacteria by 16S ribosomal RNA characterization. Proc. Natl. Acad. Sci. USA 1977, 74, 4537-4541. 
24. Lai, C.J.; Dahlberg, J.E.; Weisblum, B. Structure of an inducibly methylatable nucleotide 
sequence in 23S ribosomal ribonucleic acid from erythromycin-resistant Staphylococcus aureus. 
Biochemistry 1973, 12, 457-460. 
25. Starr, J.L.; Fefferman, R. The occurrence of methylated bases in ribosomal ribonucleic acid of 
Escherichia coli K12 W-6. J. Biol. Chem. 1964, 239, 3457-3461. 
26. Inoue, K.; Basu, S.; Inouye, M. Dissection of 16S rRNA methyltransferase (KsgA) function in 
Escherichia coli. J. Bacteriol. 2007, 189, 8510-8518. 
27. Weisblum, B.; Siddhikol, C.; Lai, C.J.; Demohn, V. Erythromycin-inducible resistance in 
Staphylococcus aureus: requirements for induction. J. Bacteriol. 1971, 106, 835-847. 
28. Thakker-Varia, S.; Ranzini, A.C.; Dubin, D.T. Ribosomal RNA methylation in Staphylococcus 
aureus and Escherichia coli: effect of the "MLS" (erythromycin resistance) methylase. Plasmid 
1985, 14, 152-161. 
29. Buriankova, K.; Doucet-Populaire, F.; Dorson, O.; Gondran, A.; Ghnassia, J.C.; Weiser, J.; 
Pernodet, J.L. Molecular basis of intrinsic macrolide resistance in the Mycobacterium tuberculosis 
complex. Antimicrob. Agents Chemother. 2004, 48, 143-150. 
30. Gu, X.; Ofengand, J.; Santi, D.V. In vitro methylation of Escherichia coli 16S rRNA by tRNA 
(m5U54)-methyltransferase. Biochemistry 1994, 33, 2255-2261. 
31. Auxilien, S.; Rasmussen, A.; Rose, S.; Brochier-Armanet, C.; Husson, C.; Fourmy, D.; Grosjean, H.; 
Douthwaite, S. Specificity shifts in the rRNA and tRNA nucleotide targets of archaeal and 
bacterial m5U methyltransferases. RNA 2011, 17, 45-53. 
Molecules 2011, 16              
 
5181
32. Pang, B.; Zhou, X.; Yu, H.; Dong, M.; Taghizadeh, K.; Wishnok, J.S.; Tannenbaum, S.R.;  
Dedon, P.C. Lipid peroxidation dominates the chemistry of DNA adduct formation in a mouse 
model of inflammation. Carcinogenesis 2007, 28, 1807-1813. 
33. Taghizadeh, K.; McFaline, J.L.; Pang, B.; Sullivan, M.; Dong, M.; Plummer, E.; Dedon, P.C. 
Quantification of DNA damage products resulting from deamination, oxidation and reaction with 
products of lipid peroxidation by liquid chromatography isotope dilution tandem mass 
spectrometry. Nat. Protoc. 2008, 3, 1287-1298. 
Sample Availability: Samples Not Available. 
© 2011 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/3.0/). 
